169 related articles for article (PubMed ID: 15614802)
21. Cyclolinopeptide A: inhibitor, immunosuppressor or other?
Benedetti E; Pedone C
J Pept Sci; 2005 May; 11(5):268-72. PubMed ID: 15838908
[No Abstract] [Full Text] [Related]
22. A heterocyclic peptide nanotube.
Horne WS; Stout CD; Ghadiri MR
J Am Chem Soc; 2003 Aug; 125(31):9372-6. PubMed ID: 12889966
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
[TBL] [Abstract][Full Text] [Related]
24. New antitumour cyclic astin analogues: synthesis, conformation and bioactivity.
Rossi F; Zanotti G; Saviano M; Iacovino R; Palladino P; Saviano G; Amodeo P; Tancredi T; Laccetti P; Corbier C; Benedetti E
J Pept Sci; 2004 Feb; 10(2):92-102. PubMed ID: 14994987
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and conformational investigation of cyclic dipeptides: 7-membered rings containing alpha- and beta-amino acids.
Müller-Hartwieg JC; Akyel KG; Zimmermann J
J Pept Sci; 2003 Mar; 9(3):187-99. PubMed ID: 12675501
[TBL] [Abstract][Full Text] [Related]
27. Cyclolinopeptides and their analogs--a new family of peptide immunosuppressants affecting the calcineurin system.
Siemion IZ; Cebrat M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1999; 47(3):143-53. PubMed ID: 10470441
[TBL] [Abstract][Full Text] [Related]
28. Thalassospiramides A and B, immunosuppressive peptides from the marine bacterium Thalassospira sp.
Oh DC; Strangman WK; Kauffman CA; Jensen PR; Fenical W
Org Lett; 2007 Apr; 9(8):1525-8. PubMed ID: 17373804
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological activity of cyclolinopeptide A analogues modified with γ
Jędrzejczak K; Hrynczyszyn P; Szczesio M; Artym J; Jastrząbek T; Kocięba M; Główka M; Huben K; Kochanowska I; Zimecki M; Zabrocki J; Jankowski S; Kolesińska B
Bioorg Med Chem; 2017 Aug; 25(16):4265-4276. PubMed ID: 28662964
[TBL] [Abstract][Full Text] [Related]
30. Solid-phase synthesis of chlorofusin analogues.
Woon EC; Arcieri M; Wilderspin AF; Malkinson JP; Searcey M
J Org Chem; 2007 Jul; 72(14):5146-51. PubMed ID: 17559272
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, conformation, and immunosuppressive activity of CLX and its analogues.
Ruchala P; Picur B; Lisowski M; Cierpicki T; Wieczorek Z; Siemion IZ
Biopolymers; 2003 Dec; 70(4):497-511. PubMed ID: 14648761
[TBL] [Abstract][Full Text] [Related]
32. Effects of Modifications on the Immunosuppressive Properties of Cyclolinopeptide A and Its Analogs in Animal Experimental Models.
Zimecki M; Kaczmarek K
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925288
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
Chen H; Du X; Tang W; Zhou Y; Zuo J; Feng H; Li Y
Bioorg Med Chem; 2008 Mar; 16(5):2403-11. PubMed ID: 18063371
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the conformations of cyclolinopeptide A in the solid state and in solution.
Tancredi T; Zanotti G; Rossi F; Benedetti E; Pedone C; Temussi PA
Biopolymers; 1989 Jan; 28(1):513-23. PubMed ID: 2720121
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of plant cyclopeptide Astin C analogues and investigation of their immunosuppressive activity.
Li F; Guo XX; Zeng GZ; Qin WW; Zhang B; Tan NH
Bioorg Med Chem Lett; 2018 Aug; 28(14):2523-2527. PubMed ID: 29871844
[TBL] [Abstract][Full Text] [Related]
36. Solution versus solid-phase cyclization strategies for large sidechain lactam-bridged peptides: a comparative study.
Camarero JA; Cairó JJ; Giralt E; Andreu D
J Pept Sci; 1995; 1(4):241-50. PubMed ID: 9223002
[TBL] [Abstract][Full Text] [Related]
37. Cyclolinopeptide A (CLA) mediates its immunosuppressive activity through cyclophilin-dependent calcineurin inactivation.
Gaymes TJ; Cebrat M; Siemion IZ; Kay JE
FEBS Lett; 1997 Nov; 418(1-2):224-7. PubMed ID: 9414131
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
39. Influence of conformational flexibility on biological activity in cyclic astin analogues.
Saviano G; Benedetti E; Cozzolino R; De Capua A; Laccetti P; Palladino P; Zanotti G; Amodeo P; Tancredi T; Rossi F
Biopolymers; 2004; 76(6):477-84. PubMed ID: 15372484
[TBL] [Abstract][Full Text] [Related]
40. The structure of cyclolinopeptide A in chloroform refined by RDC measurements.
Huben K; Jewgiński M; Pabis A; Paluch P; Luy B; Jankowski S
J Pept Sci; 2014 Nov; 20(11):901-7. PubMed ID: 25111589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
